Researchers Find A Promising New Approach For Treating Liver Cirrhosis

News In a study in The American Journal of Pathology, investigators report that treatment with aleglitazar reduced inflammation, vasoconstriction, angiogenesis, mucosal disruption, and tumor necrosis factor (TNF)--α overproduction in cirrhotic rats with PH. This suggests a ... Contributed Author: ELSEVIER Topics: Medical Diagnostics